Amerila, Aira S.
HRN: 22-71-11 Sex: FemalePatient Encounter
Audit Details
Audit Date
Antimicrobial
Start Date
End Date
Route
Dose
Frequency
Indication Documented
11/17/2023
CEFUROXIME 750MG (VIAL)
11/17/2023
11/24/2023
IV
240mg
Q8H
PCAP C
Waiting Final Action
Indication: ProphylaxisEmpiric Type of Infection: Pneumonia Compliance to guidelines: Compliant To Guidelines
Final appropriateness: Yes
Overall appropriateness: Yes